Literature DB >> 22298981

Management of nondysplastic barrett esophagus with ablation therapy.

Richard E Sampliner1.   

Abstract

Entities:  

Year:  2011        PMID: 22298981      PMCID: PMC3264895     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


× No keyword cloud information.
  9 in total

1.  Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus.

Authors:  Prateek Sharma; Gary W Falk; Allan P Weston; Dean Reker; Mark Johnston; Richard E Sampliner
Journal:  Clin Gastroenterol Hepatol       Date:  2006-04-17       Impact factor: 11.382

2.  Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus.

Authors:  Kenneth K Wang; Richard E Sampliner
Journal:  Am J Gastroenterol       Date:  2008-03       Impact factor: 10.864

Review 3.  Management of nondysplastic Barrett's esophagus: where are we now?

Authors:  Prateek Sharma; Gary W Falk; Richard Sampliner; Stuart Jon Spechler; Kenneth Wang
Journal:  Am J Gastroenterol       Date:  2009-04       Impact factor: 10.864

4.  Endoscopic radiofrequency ablation for Barrett's esophagus: 5-year outcomes from a prospective multicenter trial.

Authors:  D E Fleischer; B F Overholt; V K Sharma; A Reymunde; M B Kimmey; R Chuttani; K J Chang; R Muthasamy; C J Lightdale; N Santiago; D K Pleskow; P J Dean; K K Wang
Journal:  Endoscopy       Date:  2010-09-20       Impact factor: 10.093

Review 5.  The case for endoscopic treatment of non-dysplastic and low-grade dysplastic Barrett's esophagus.

Authors:  David E Fleischer; Robert Odze; Bergein F Overholt; John Carroll; Kenneth J Chang; Ananya Das; John Goldblum; Daniel Miller; Charles J Lightdale; Jeffrey Peters; Richard Rothstein; Virender K Sharma; Daniel Smith; Victor Velanovich; Herbert Wolfsen; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2010-04-20       Impact factor: 3.199

6.  Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus.

Authors:  Hashem B El-Serag; Thomas V Aguirre; Stephanie Davis; Mark Kuebeler; Achyut Bhattacharyya; Richard E Sampliner
Journal:  Am J Gastroenterol       Date:  2004-10       Impact factor: 10.864

Review 7.  A cost-utility analysis of ablative therapy for Barrett's esophagus.

Authors:  John M Inadomi; Ma Somsouk; Ryan D Madanick; Jennifer P Thomas; Nicholas J Shaheen
Journal:  Gastroenterology       Date:  2009-03-06       Impact factor: 22.682

8.  Radiofrequency ablation in Barrett's esophagus with dysplasia.

Authors:  Nicholas J Shaheen; Prateek Sharma; Bergein F Overholt; Herbert C Wolfsen; Richard E Sampliner; Kenneth K Wang; Joseph A Galanko; Mary P Bronner; John R Goldblum; Ana E Bennett; Blair A Jobe; Glenn M Eisen; M Brian Fennerty; John G Hunter; David E Fleischer; Virender K Sharma; Robert H Hawes; Brenda J Hoffman; Richard I Rothstein; Stuart R Gordon; Hiroshi Mashimo; Kenneth J Chang; V Raman Muthusamy; Steven A Edmundowicz; Stuart J Spechler; Ali A Siddiqui; Rhonda F Souza; Anthony Infantolino; Gary W Falk; Michael B Kimmey; Ryan D Madanick; Amitabh Chak; Charles J Lightdale
Journal:  N Engl J Med       Date:  2009-05-28       Impact factor: 91.245

9.  An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett's esophagus.

Authors:  A Das; C Wells; H J Kim; D E Fleischer; M D Crowell; V K Sharma
Journal:  Endoscopy       Date:  2009-05-05       Impact factor: 10.093

  9 in total
  1 in total

1.  Managing Barrett's esophagus with radiofrequency ablation.

Authors:  Junichi Akiyama; Andrew Roorda; George Triadafilopoulos
Journal:  Gastroenterol Rep (Oxf)       Date:  2013-03-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.